Torrent is only recalling lots of losartan-containing products that contain N-Methylnitrosobutyric acid (NMBA) above the acceptable daily intake levels released by the FDA, it added.
In a regulatory filing, Cipla said 99.68 percent shareholders polled in favour of the resolution to raise funds.
China is the second largest pharmaceutical market globally with total spending of $137 billion in 2018.
This is anticipated to be one of the largest financing rounds in the country which is likely to close over the next 45 days,
The merger of Pfizer’s Upjohn division and Mylan may not only attempt to solve their problems in the US market but also make inroads into emerging markets, particularly China
The submission came during hearing of a plea seeking contempt action against the e-pharmacies for continuing to sell drugs online despite a high court order staying such activity.
A top Commerce Department official recently said India pressed China to import more Indian goods, especially pharmaceutical and IT products.
In this podcast, Rakesh Sharma takes a detailed look at the price-rigging controversy, the predicament Indian pharmaceuticals face, and what the future holds for these companies.
Lupin’s shares fell after an FDA inspection led to its US unit being issued an adverse warning. Other pharma companies too have tripped on inspections, raising fears that compliance issues are very much alive for the industry
In a notification, the National Pharmaceutical Pricing Authority said it has fixed retail prices of 22 formulations and has revised ceiling price of 14 formulations.
Dr Reddy’s generic Suboxone launch is set to be a reality. A much-awaited event, a mounting threat from competitors may limit its benefits
The company has received approval from the US Food and Drug Administration to market a generic version of Eli Lilly and Company's Adcirca tablets in 20 mg strength.
The drug firm said it denies any wrongdoing and intends to vigorously defend against these claims.
The product will be manufactured at the group's formulations manufacturing facility at a special economic zone in Ahmedabad.
Zydus group now has 237 approvals from the USFDA and has so far filed over 340 abbreviated new drug applications.
Both pharmaceutical and IT sectors are showing positive movement on the back of a weak rupee.
Here's a playlist of the best podcasts covering various events over the week.
The audit of API Mirfield plant in the UK by the US Food and Drug Administration (FDA) was completed on Friday, Dr Reddy's said in a regulatory filing to stock exchanges.
The BSE Healthcare index gained 0.96 percent in the past week, the benchmark Sensex rose 0.43 percent.
The company has received the final approval from the United States Food and Drug Administration (USFDA) to market Ziprasidone Hydrochloride capsules.
If the drug gets USFDA's nod, Biocon will become the first Indian drug maker to crack highly regulated US market for biosimilars.
Last week was all about fourth quarter results, debate over generic drugs and drug price control measures.
According to an EY report, outbound and domestic transactions drove most of the deal activity in 2016, with 21 deals each. In terms of disclosed deal value, the deal size stood at USD 2.1 billion each.
Watch Mankind Pharma’s journey from being a small family-run enterprise to becoming present in over 15 countries around the world.